Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
NovoCure Limited (NVCR) had Return on Tangible Equity of -21.51% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$174.06M |
|
$-71.14M |
|
$38.93M |
|
$135.13M |
|
$241.47M |
|
$-67.42M |
|
$-1.84M |
|
$-69.26M |
|
$-69.26M |
|
$-71.14M |
|
$-71.14M |
|
$-71.14M |
|
$-71.14M |
|
$-67.42M |
|
$-65.91M |
|
114.15M |
|
114.15M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$631.66M |
|
$99.59M |
|
$156.26M |
|
$787.93M |
|
$217.58M |
|
$234.94M |
|
$239.63M |
|
$457.21M |
|
$330.72M |
|
$330.72M |
|
$330.72M |
|
115.82M |
|
| Cash Flow Statement Financials | |
$-13.52M |
|
$7.75M |
|
$-0.17M |
|
$103.39M |
|
$97.32M |
|
$-6.07M |
|
$63.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.90 |
|
-- |
|
-- |
|
0.42 |
|
0.71 |
|
77.63% |
|
-38.73% |
|
-38.73% |
|
-- |
|
-39.79% |
|
-40.87% |
|
$-18.67M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.90 |
|
1.19 |
|
75.70 |
|
-21.51% |
|
|
Return on Tangible Equity |
-21.51% |
-9.03% |
|
-12.58% |
|
$2.86 |
|
$-0.16 |
|
$-0.12 |
|